JBM  Vol.7 No.3 , March 2019
Decrease in the Hospital Stay of Neonates with Suspected Nosocomial Sepsis with the Use of a Molecular Biology Technique
Abstract: Introduction: Diagnostic alternatives that allow microbial identification in blood, such as molecular biology; have shown utility in neonatal sepsis. Objective: To evaluate the impact of a Light Cycler SeptiFast test (LCSF) on days of hospital stay and the use of newborn (NB) antibiotics with suspected sepsis. Methods: We included NB with LCSF test and blood culture (cases) and NB with only blood culture (controls). We evaluated the days of stay, days of antimicrobial use and number of deaths. Statistic analysis: Descriptive statistics was used. The association between the use of LCSF and variables such as mortality, days of stay, use of antimicrobials, and use of mechanical ventilation was analyzed by odds ratio with 95% CI. Results: We included 20 subjects in the case group and 40 in the control group. 8 (40%) of the cases were positive vs 6 (15%) of the controls in the control group. In the controls, the average days of stay were 65 + 15 vs 35 + 10 days of the cases (p < 0.05). There was no significant difference in mortality, nor in antimicrobial use. The use of molecular biology was a protective factor for prolonged stay OR 0.2 (95% CI 0.08 - 0.5) p = 0.001. Conclusions: The LCSF test influences the days of hospital stay, but does not impact mortality or the use of antimicrobials.
Cite this paper: Reyna-Figueroa, J. , Rodríguez-Sánchez, M. , Matsumoto, P. , Ortiz-Ibarra, F. and Limón-Rojas, A. (2019) Decrease in the Hospital Stay of Neonates with Suspected Nosocomial Sepsis with the Use of a Molecular Biology Technique. Journal of Biosciences and Medicines, 7, 44-51. doi: 10.4236/jbm.2019.73005.

[1]   Jiménez, P.R. (2004) Indicadores de calidad y eficiencia de los servicios hospitalarios. Una mirada actual. Rev Cubana Salud Pública, 30, 27-32.

[2]   Reyna, F.J., Ortiz, I.F.J., Esteves, J.A. and Reyna, F.J. (2009) Costo económico marginal del fracaso terapéutico con ampicilina más amikacina en el tratamiento de la sepsis neonatal temprana [Cost of Therapeutic Failure of Ampicillin plus Amikacin in the Treatment of Early Neonatal Sepsis]. Anales de Pediatría, 71, 54-59.

[3]   Torres, E., Pérez, M., Pedrosa, I., Peña, M., Jiménez, M. and Pérez, M. (2013) Evaluación de la técnica LightCycler® SeptiFast en recién nacidos y lactantes con sospecha de sepsis [Evaluation of the LightCycler® SeptiFast Test in Newborns and Infants with Clinical Suspicion of Sepsis]. Enfermedades Infecciosas y Microbiología Clínica, 31, 375-379.

[4]   Troger, B., Hartel, C., Buer, J., Dordelmann, M., Felderhoff-Muser, U., Hohn, T., et al. (2016) Clinical Relevance of Pathogens Detected by Multiplex PCR in Blood of Very Low Birth Weight Infants with Suspected Sepsis—Multicentre Study of the German Neonatal Network. PLoS ONE, 11, e0159821.

[5]   Korber, F., Zeller, I., Grünsäudl, M., Willinger, B., Apfalter, P., Hirschl, A. and Makristathis, A. (2017) SeptiFast versus Blood Culture in Clinical Routine—A Report on 3 Years’ Experience. Wiener Klinische Wochenschrift, 129, 427-434.

[6]   Straub, J., Paula, H., Mayr, M., Kasper, D., Assadian, O., Berger, A., et al. (2017) Diagnostic Accuracy of the ROCHE SeptiFast PCR System for the Rapid Detection of Blood Pathogens in Neonatal Sepsis—A Prospective Clinical Trial. PLoS ONE, 12, e0187688.

[7]   Gies, F., Tschiedel, E., Felderhoff-Müser, U., Rath, P.M., Steinmann, J. and Dohna-Schwake, C. (2016) Prospective Evaluation of SeptiFast Multiplex PCR in Children with Systemic Inflammatory Response Syndrome under Antibiotic Treatment. BMC Infectious Diseases, 16, 378.

[8]   Kasper, D.C., Altiok, I., Mechtler, T.P., Bohm, J., Straub, J., Langgarrtner, M., Pollak, A., Herkner, K.R. and Berger, A. (2013) Molecular Detection of Late-Onset Neonatal Sepsis in Premature Infants Using Small Blood Volumes: Proof-of-Concept. Neonatology, 103, 268-273.

[9]   Ortiz, I.F.J., Treviño, V.P., Valenzuela, M.E., Limon, R.A.E., Lara, F.G., Ceballos, B.A., Morales, M.I., Fernandez, C.L., Covian, M.E. and Reyna, F.J. (2015) Evaluation of the Ligth-Cycler SeptiFast Test in Newborns with Suspicion of Nosocomial Sepsis. Iranian Journal of Pediatrics, 25, e253.

[10]   Reyna, F.J., Briseño, V.R. and Ortiz, I.F.J. (2005) Validación de la escala NOSEP-1 para el diagnóstico de sepsis nosocomial en recién nacidos prematuros menores de 1500 g [Diagnosis of Nosocomial Sepsis in Neonates under 1500 g by Means of NOSEP-I Score]. Boletín médico del Hospital Infantil de México, 62, 321-28.

[11]   Mahieu, M.L., de Muynck, O.A., de Dooy, J.J., Laroche, M.S. and Van Acker, J.K. (2000) Prediction of Nosocomial Sepsis in Neonates by Means of a Computer-Weighted Bedside Scoring System (NOSEP Score). Critical Care Medicine, 28, 2026-2033.

[12]   Klein, O.J. (2001) Bacterial Sepsis and Meningitis. In: Remington, J.S. and Klein, J.O., Eds., Infectious Diseases of the Fetus and Newborn Infant, 5th Edition, WB Saunders, Philadelphia, 550-553.

[13]   Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J. and Pinsky, M.R. (2001) Epidemiology of Severe Sepsis in the United States: Analysis of Incidence, Outcome, and Associated Costs of Care. Critical Care Medicine, 29, 1303-1310.

[14]   Gonzalez, G.L. (2009) Severe Sepsis and Septic Shock in Children: Not All Has Been Said. Revista Panamericana de Salud Pública, 26, 562-564.

[15]   Shane, A.L., Sánchez, P.J. and Stoll, BJ. (2017) Neonatal Sepsis. The Lancet, 390, 1770-1780.

[16]   Mussap, M., Molinari, M.P., Senno, E., Gritti, P., Soro, B., Mannelli, S. and Fabris, C. (2007) New Diagnostic Tools for Neonatal Sepsis: The Role of a Real-Time Polymerase Chain Reaction for the Early Detection and Identification of Bacterial and Fungal Species in Blood Samples. Journal of Chemotherapy, No. 2, 31-34.

[17]   Alvarez, J., Mar, J., Varela, E., Garea, M. and Martinez, L. (2012) Cost Analysis of Real-Time Polymerase Chain Reaction Microbiological Diagnosis in Patients with Septic Shock. Anaesthesia and Intensive Care, 40, 958-963.

[18]   Softic, I., Tahirovic, H., Di Ciommo, V. and Auriti, C. (2017) Bacterial Sepsis in Neonates: Single Centre Study in a Neonatal Intensive Care Unit in Bosnia and Herzegovina. Acta Medica Academica, 46, 7-15.

[19]   Markota, A. and Sinkovic, A. (2018) Mortality, Intensive Care Treatment, and Cost Evaluation: Role of a Polymerase Chain Reaction Assay in Patients with Sepsis. Journal of International Medical Research, 46, 79-88.

[20]   Reyna, J., Ortiz, J. and Morales, I. (2010) Use of the LightCycler SeptiFast Test for Rapid Etiologic Diagnosis of Nosocomial Infection in Gynecological Sepsis. Gynecologic and Obstetric Investigation, 70, 215-216.

[21]   Maldonado, S.K., Reyna, F.J., Ortiz, I.F.J., Valenzuela, M.E. and Limón, R.A.E. (2011) Uso de la prueba lightCycler® Septifast en un recién nacido y un lactante para el diagnóstico etiológico rápido de sepsis nosocomial por Candida parapsilosis. Revista de Enfermedades Infecciosas en Pediatría, 25, 75-78.

[22]   Meisner, M. (2005) Biomarkers of Sepsis: Clinically Useful? Current Opinion in Critical Care, 11, 473-480.

[23]   Chauhan, N., Tiwari, S. and Jain, U. (2017) Potential Biomarkers for Effective Screening of Neo-natal Sepsis Infections: An Overview. Microbial Pathogenesis, 107, 234-242.

[24]   Sharma, D., Farahbakhsh, N., Shastri, S. and Sharma, P. (2018) Biomarkers for Diagnosis of Neonatal Sepsis: A Literature Review. The Journal of Maternal-Fetal & Neonatal Medicine, 31, 1646-1659.

[25]   Westh, H., Lisby, G., Breysse, F., Boddinghaus, B., Chomarat, M., Gant, V., et al. (2009) Multi-plex Real-Time PCR and Blood Culture for Identification of Bloodstream Pathogens in Patients with Suspected Sepsis. Clinical Microbiology and Infection, 15, 544-551.